Upload Avatar (500 x 500)
Chuanhui Han
Basic Medical Sciences
Peking University
Beijing
Language: Chinese, English
Tumor
Immunology
Immune
Tolerance
Mechanisms
Novel
Cancer
Therapies
Development
Research
Areas of Focus
- Tumor immunology
- Tumor immune tolerance mechanisms
- Development of novel cancer immunotherapies
Work Experience
- 2021.12-Present Assistant Professor (Tenure-track), Peking University International Cancer Institute
- 2016-2021 Postdoctoral Researcher, University of Texas Southwestern Medical Center
Academic Background & Achievements
- 2005-2009 Bachelor: Beijing Institute of Technology
- 2009-2015 PhD: Institute of Biophysics, Chinese Academy of Sciences
- Published over 20 papers in renowned journals
Publications
- The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation, Han C*, Godfrey V*, Liu Z, Han Y, Liu L, Peng H, Hasan Z#, Fu Y#, 2021
- Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling, Han C*, Liu Z*, Zhang Y, Shen A, Dong C, Zhang A, Moor C, Cao X, Ren Z, Lu C, Qiao J#, Fu Y#, 2020
- β-catenin regulates tumor-derived PD-L1, Han C, Fu Y, 2020
- Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy, Han C. Zhang A, Liu Z, C Moore. Fu Y#, 2020
- Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity, Liu Z*, Han C*, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu Y#, 2019
